Dormond O - Search Results

1

[Isolated left ventricular hypertrophy : is it a Fabry disease?].

Barbey F, Dormond O, Monzambani V, Barbey G, Namdar M, Monney P. Barbey F, et al. Among authors: dormond o. Rev Med Suisse. 2020 Oct 7;16(709):1886-1890. Rev Med Suisse. 2020. PMID: 33026733 Review. French.

2

Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease.

Brakch N, Dormond O, Bekri S, Golshayan D, Correvon M, Mazzolai L, Steinmann B, Barbey F. Brakch N, et al. Among authors: dormond o. Eur Heart J. 2010 Jan;31(1):67-76. doi: 10.1093/eurheartj/ehp387. Epub 2009 Sep 22. Eur Heart J. 2010. PMID: 19773225 Free article.

3

Thoracic aortic dilation/aneurysm in Fabry disease.

Dormond O, Barbey F. Dormond O, et al. Am J Med. 2013 Dec;126(12):e23. doi: 10.1016/j.amjmed.2013.07.029. Am J Med. 2013. PMID: 24262735 No abstract available.

4

Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study.

Franzen DP, Nowak A, Haile SR, Mottet D, Bonani M, Dormond O, Kohler M, Krayenbuehl PA, Barbey F. Franzen DP, et al. Among authors: dormond o. PLoS One. 2017 Jul 25;12(7):e0180437. doi: 10.1371/journal.pone.0180437. eCollection 2017. PLoS One. 2017. PMID: 28742806 Free PMC article. Clinical Trial.

5

Ascending aortic remodelling in Fabry disease after long-term enzyme replacement therapy.

Monney P, Qanadli SD, Hajdu S, Tran C, Schwitter J, Dormond O, Barbey F. Monney P, et al. Among authors: dormond o. Swiss Med Wkly. 2017 Nov 9;147:w14517. doi: 10.4414/smw.2017.14517. eCollection 2017. Swiss Med Wkly. 2017. PMID: 29120015 Free article.

6

Hypermobile Ehlers-Danlos-like syndrome in Fabry disease.

Barbey F, Lidove O, Dormond O. Barbey F, et al. Among authors: dormond o. Clin Genet. 2019 May;95(5):627-628. doi: 10.1111/cge.13497. Epub 2019 Jan 15. Clin Genet. 2019. PMID: 30644091 No abstract available.

7

[Chaperone molecules: The example of Fabry disease].

Barbey F, Monney P, Dormond O. Barbey F, et al. Among authors: dormond o. Nephrol Ther. 2021 Apr;17S:S11-S22. doi: 10.1016/j.nephro.2020.02.005. Nephrol Ther. 2021. PMID: 33910691 Free article. French.

8

Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity.

Nowak A, Dormond O, Monzambani V, Huynh-Do U, Barbey F. Nowak A, et al. Among authors: dormond o. Mol Genet Metab. 2022 Sep-Oct;137(1-2):173-178. doi: 10.1016/j.ymgme.2022.08.003. Epub 2022 Aug 23. Mol Genet Metab. 2022. PMID: 36087505 Free article.

9

Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.

Gatterer C, Beitzke D, Graf S, Lenz M, Sunder-Plassmann G, Mann C, Ponleitner M, Manka R, Fritschi D, Krayenbuehl PA, Kamm P, Dormond O, Barbey F, Monney P, Nowak A. Gatterer C, et al. Among authors: dormond o. Life (Basel). 2023 May 19;13(5):1213. doi: 10.3390/life13051213. Life (Basel). 2023. PMID: 37240859 Free PMC article.

10

Manganese-induced integrin affinity maturation promotes recruitment of alpha V beta 3 integrin to focal adhesions in endothelial cells: evidence for a role of phosphatidylinositol 3-kinase and Src.

Dormond O, Ponsonnet L, Hasmim M, Foletti A, Rüegg C. Dormond O, et al. Thromb Haemost. 2004 Jul;92(1):151-61. doi: 10.1160/TH03-11-0728. Thromb Haemost. 2004. PMID: 15213856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters